This site is intended for healthcare professionals only
LoginRegister
Johnson and Johnson Told to Justify Phase III Icotrokinra Trial Design Over Sample Size, Patient ExposureJohnson and Johnson Told to Justify Phase III Icotrokinra Trial Design Over Sample Size, Patient...
Zydus Lifesciences bags USFDA nod for high BP tabletZydus Lifesciences bags USFDA nod for high BP tablet
Thermo Fisher expands India footprint with Customer Experience, Bioprocess Design Centers at Genome ValleyThermo Fisher expands India footprint with Customer Experience, Bioprocess Design Centers at Genome...
Scan, Call, Report: Telangana makes Adverse Drug Reactions reporting easyScan, Call, Report: Telangana makes Adverse Drug Reactions reporting easy
Aurobindo Pharma China Plant incurring loss, break even expected by Q4Aurobindo Pharma China Plant incurring loss, break even expected by Q4
Indore SEZ exports surge 32 percent on strong pharma demandIndore SEZ exports surge 32 percent on strong pharma demand
Novartis concludes acquisition of Tourmaline BioUSFDA greenlights Novartis gene replacement therapy for spinal muscular atrophy
Over 4000 medical device manufacturing sites licensed since 2021, Minister tells ParliamentAiMeD Hails CDSCO Medical Device Licensing Mandate but Flags Loophole for Foreign Certifications
CDSCO Launches Online Risk Classification Module for Non-IVD Medical DevicesIndian Licensing Now Mandatory for All Medical Device Procurements
Medicines Arent Groceries: AIOCD Urges PM to Shut Down Illegal Online Pharmacies After Blinkit StingNo More Online Ads for Prescription Drugs? Govt Proposes Ban on Schedule G, H, H1 and X Medicines
Sun Pharma Asked to Resubmit Revised Phase III Protocol for Delafloxacin CABP TrialSun Pharma Gets CDSCO Panel Nod to Conduct Active Post-Marketing Study for Antacid Combination...
Odisha launches Pharmaceutical and Medical Devices Policy 2025, eyes Rs 25000 cr investmentPeople Tree Hospitals founder kicks off BlackRock's Rs 210-crore exit amid expansion push
X